Eidos Therapeutics, Inc. Insider Trading for July 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eidos Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eidos Therapeutics, Inc. for July 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 38.35 | 33 | 1,266 | 346,081 | 346.1 K to 346.1 K (-0.01 %) |
| Jul 29 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 37.31 | 700 | 26,117 | 346,114 | 346.8 K to 346.1 K (-0.20 %) |
| Jul 29 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 36.53 | 1,300 | 47,485 | 346,814 | 348.1 K to 346.8 K (-0.37 %) |
| Jul 29 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Sell | S | 35.65 | 2,967 | 105,760 | 348,114 | 351.1 K to 348.1 K (-0.85 %) |
| Jul 29 2019 | EIDX | Eidos Therapeutics ... | Sinha Uma | Chief Scientific Of ... | Grant | A | 12.01 | 1,769 | 21,247 | 351,081 | 349.3 K to 351.1 K (+0.51 %) |
| Jul 17 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 40.04 | 15,000 | 600,561 | 501,527 | 516.5 K to 501.5 K (-2.90 %) |
| Jul 17 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Grant | A | 12.01 | 1,769 | 21,247 | 2,850 | 1.1 K to 2.9 K (+163.64 %) |
| Jul 12 2019 | EIDX | Eidos Therapeutics ... | Siu Christine | CFO and Secretary | Option Exercise | M | 0.59 | 5,000 | 2,950 | 217,191 | |
| Jul 12 2019 | EIDX | Eidos Therapeutics ... | Siu Christine | CFO and Secretary | Sell | S | 39.37 | 5,000 | 196,850 | 36,470 | 41.5 K to 36.5 K (-12.06 %) |
| Jul 12 2019 | EIDX | Eidos Therapeutics ... | Siu Christine | CFO and Secretary | Buy | M | 0.59 | 5,000 | 2,950 | 41,470 | 36.5 K to 41.5 K (+13.71 %) |
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | Kumar Neil | Chief Executive Off ... | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | Kumar Neil | Chief Executive Off ... | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | AGUIAR ERIC | Director | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | AGUIAR ERIC | Director | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma, Inc. | 10% Owner | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma, Inc. | 10% Owner | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |